Clinical Trial Update: Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major [Phase 4]

View source ↗

Summary

Phase 4 trial update on intensive combined chelation therapy for iron-induced cardiomyopathy in patients with thalassemia major; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Cardiomyopathy
• Thalassemia Major

Snippet

Sponsor: Ospedale Microcitemico | Conditions: Iron Overload, Cardiomyopathy | Phase 4 | Status: COMPLETED